The largest database of trusted experimental protocols

7 protocols using adenosine

1

Adenosine Signaling in Cardiac Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Murine CFs were isolated from healthy A2bR–/– mice or their littermate controls by collagenase digestion using the Langendorff methods and magnetic bead–mediated enrichment as described above. Isolated CFs were cultivated in DMEM complete (4,500 mg/L glucose, 20% FCS, 1% penicillin and streptomycin, 1% GlutaMAX). All experiments were conducted with cells in passage 2: 60,000 CFs were seeded per well of a 12-well plate and permitted to settle overnight (passage 2). Cells were washed with DMEM complete and incubated with 400 μL DMEM complete containing 33 μM erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) (an adenosine deaminase [ADA] inhibitor, Tocris) and 33 μM nitrobenzylthioinosine (NBMPR) (an inhibitor of equilibrative nucleoside transporter 1 ENT1, Tocris), with or without 1 μM FR900359 (a Gq inhibitor, provided by Evi Kostenic, University of Bonn, Bonn, Germany) for 10 minutes at 37°C. Afterwards, 100 μL DMEM complete was added and contained (besides 33 μM EHNA and 33 μM NBMPR with or without 1 μM FR900359) 100 μM adenosine (Tocris) or only the corresponding amount of DMSO (vehicle control), giving a final concentration of 20 μM adenosine. After incubation for 24 hours, supernatant was collected and used for cytokine analysis with Bioplex technology (Bio-Rad) or IL-11 ELISA (Thermo Fisher Scientific). Cells were washed with PBS and used for mRNA expression analysis.
+ Open protocol
+ Expand
2

Neurotransmitter Receptor Pharmacology

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serotonin (5-HT), N-methyl-d-aspartate (NMDA) and dopamine were purchased from Sigma and stocks and prepared in de-ionized water and later diluted in regular mouse ringer or normal aCSF. Caffeine, the A1 receptor antagonist DPCPX (8-cyclopentyl-1,3-dipropylxanthine), the A2A receptor antagonist SCH58261 (5-amino-7-(β-phenylethyl)-2-(8-furyl) pyrazolol [4,3-e] - 1,2,4 - triazolol [1,5-c] pyrimidine), adenosine, the A1 receptor agonist N-Cyclopentyladenosine (CPA), the A2A receptor agonist CGS21680, the D1 receptor antagonist SCH23390 ((R)-(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride) hydrochloride, the D2 receptor antagonist sulpiride ((S)-(−)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide), the cAMP-dependent protein kinase (PKA) inhibitor 14–22 amide myristoylated and the adenylyl cyclase activator Forskolin were purchased from Tocris (St. Louis, Missouri). Caffeine was prepared in de-ionized water and later dissolved in regular mouse ringer or normal aCSF whereas the adenosine and dopamine receptor agonists and antagonists were prepared as stock solutions in Dimethyl Sulphoxide (DMSO) or de-ionized water (depending on solubility) and later diluted in de-ionized water.
+ Open protocol
+ Expand
3

Drug Treatment Protocols and Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adenosine (Tocris, 3624), FTI-277 (Selleckchem, S7465), GGTI-298 (Tocris, 2430), istradefylline (KW-6002, MedChemExpress HY-10888), NB-598 maleate (AdooQ, A15180–10), simvastatin (Selleckchem, S1792), pitavastatin (Selleckchem, S1759), thapsigargin (Sigma-Aldrich, 586005), thiostrepton (Sigma-Aldrich, 598226), and YM-53601 (Cayman, 18113) were dissolved in DMSO (Thermo Fisher Scientific BP231), and stock solutions were aliquoted and stored at −80°C. FPP (Cayman 63250) and GGPP (Cayman 63330) were supplied as a solution of methanol:NH4OH (70:30) and stored at −20°C. Baclofen (MedChemExpress, HY-B0007) and caffeine (Tocris, 2793) were dissolved in H2O and mevalonolactone (Sigma-Aldrich M4667) was diluted with H2O and stored at −20°C. Cells were treated with individual or combinations of drugs or small molecules at indicated concentrations for various times and collected for trypan blue exclusion assay, qRT-PCR or immunoblotting.
+ Open protocol
+ Expand
4

Pharmacological Compounds for Cell Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adenosine, NECA, CGS-21680, PSB-0777, LUF-5834 and SCH-58261 were purchased from Tocris Biosciences (Bristol, UK). HEPES was purchased from SigmaAldrich (St. Louis, MO, US). Stock solutions were prepared in DMSO. Aliquots of these stock solutions were kept frozen at −20 °C until use.
+ Open protocol
+ Expand
5

Investigating STAT1-IRF1 Signaling Cascades

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary antibodies were as follows: P-STAT1 (CST 7649), β-actin (CST 3700), T-STAT1 (CST 9172), IRF1 (CST 8478), P-TBK1 (CST 5483), IRF3 (CST 11904), p65 (CST 8242), LaminA/C (CST 4777), T-TBK1 (Abcam ab40676), α-Tubulin (Abcam ab52866). Pharmacological tools were as follows: UTP (Sigma U6875), SLIGKV-NH2 (Tocris 4153), ATP (Sigma A6419), Adenosine (Tocris 3624), AR-C 118925XX (Tocris 4890), histamine (Tocris 3545), BTP2 (Sigma 203890), cetirizine (Tocris 2577), YM-254890 (Cayman Chemical 29735), Gö 6983 (Tocris 2285), GF 109203X (Tocris 0741), PDBu (Tocris 4153), PMA (Tocris 1201), ruxolitinib (Tocris 7054), ARL 67156 (Tocris 1283), NECA (Tocris 1691), IFN-β (R & D systems 8499-IF), poly(I:C) (Invivogen tlrl-picw), 2,3 cGAMP (Invivogen tlrl-nacga23), ISD (Invivogen tlrl-isdn), 3p-hpRNA (Invivogen tlrl-hprna).
+ Open protocol
+ Expand
6

Adenosine Regulation of Splenic Lymphocyte Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenic lymphocytes were collected by lyzing tissue in a Dounce homogenizer, followed by layering over Ficoll Paque (GE health care, Chicago, IL, USA), as described previously (21) .
Balb/c splenic lymphocytes (3 × 10 6 ) were mixed with SJL/J splenic lymphocytes (3 × 10 6 ) in 500 µL of DMEM medium containing 10% FCS, 100 U/ml penicillin, 100 µg/mL streptomycin, 2 mM L-glutamine, 1 mM sodium pyruvate, and 50 µM 2-mercaptoethanol (D10 medium) in 24 well plates in the presence of adenosine (0-1 mM) (Sigma, St. Louis, MO, USA); in the presence of each adenosine receptor agonist (0-10 µM) (A1R: 2-Chloro-N6-cyclopentyladenosine (CCPA), Tocris, Bristol, UK; A2aR: PSB0777, Tocris; A2bR: BAY 60-6583, Tocris; A3R: HEMADO, Tocris); in the presence of A2aR antagonist (0-1 nM) (Istradefylline, Sigma) plus adenosine (100 µM); in the presence of an adenyl cyclase inhibitor (0-1 µM) (MDL-12330A, Enzo Life Sciences, Farmingdale, NY, USA) or a protein kinase A inhibitor (0-1 µM) (H-89, Tocris) plus adenosine (100 µM) to inhibit A2aR signaling; or in the presence of a CD39 inhibitor (0-1 µM) (ARL67156, Tocris) or a CD73 inhibitor (0-1 µM) (adenosine 5'-(α, β-methylene) diphosphate (AMP-CP; Tocris) plus ATP (100 µM) (GE healthcare). After mixing, the plates were incubated for 7 days at 37°C. The supernatants were collected for use in cytokine ELISAs.
+ Open protocol
+ Expand
7

Pharmacological Modulation of Adenosine Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compounds (10 μM of AppCH 2 ppA), 10 μM of adenosine, 40 nM of 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) (Tocris Bioscience, Bristol, UK), 10 μg/mL of adenosine deaminase (ADA) (Merck, Darmstadt, Germany), 100 μM of suramin hexasodium salt, 10 nM of MRS2500 tetraammonium salt (Tocris Bioscience, Bristol, UK), 100 nM of tertiapin-Q (Tocris Bioscience, Bristol, UK), 100 μM of adenosine 5′-(α,β-methylene) diphosphate (ADP-methylene) (Merck, Darmstadt, Germany) and 500 μM of bupivacaine were added to ACSF-2 and superfused with the same rate as control solution. Inosine (Merck, Darmstadt, Germany) at concentration of 100 μM was added to Kglu intracellular solution.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!